{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "DecreaseAmount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9BRP0",
      "entity_text" : "OVOL2",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0172" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "XREF_BIBR It also remains plausible that OVOL2 is expressed in vivo at developmental stages not currently investigated and that the promoter mutations identified could lead to loss, or downregulation, of OVOL2 at a crucial time point in eye development.",
  "reading_complete" : "2020-08-08T14:09:15Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T14:06:07Z",
  "trigger" : "loss",
  "evidence" : [ "loss, or downregulation, of OVOL2" ],
  "pmc_id" : "4716680",
  "score" : 0
}